These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24557045)

  • 1. Immunology of major depression.
    Müller N
    Neuroimmunomodulation; 2014; 21(2-3):123-30. PubMed ID: 24557045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N; Schwarz MJ
    Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of schizophrenia.
    Müller N
    Neuroimmunomodulation; 2014; 21(2-3):109-16. PubMed ID: 24557043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
    Müller N
    Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological aspects of the treatment of depression and schizophrenia.
    Müller N
    Dialogues Clin Neurosci; 2017 Mar; 19(1):55-63. PubMed ID: 28566947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in schizophrenia.
    Müller N; Weidinger E; Leitner B; Schwarz MJ
    Front Neurosci; 2015; 9():372. PubMed ID: 26539073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.
    Na KS; Jung HY; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():277-86. PubMed ID: 23123365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
    Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L
    Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibition in schizophrenia and major depression.
    Müller N; Schwarz MJ
    Curr Pharm Des; 2008; 14(14):1452-65. PubMed ID: 18537668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Oxenkrug GF
    Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
    Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
    Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory biomarkers and depression.
    Müller N; Myint AM; Schwarz MJ
    Neurotox Res; 2011 Feb; 19(2):308-18. PubMed ID: 20658274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.
    Steiner J; Bogerts B; Sarnyai Z; Walter M; Gos T; Bernstein HG; Myint AM
    World J Biol Psychiatry; 2012 Oct; 13(7):482-92. PubMed ID: 21707463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
    Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF
    J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory markers in depression.
    Dinan TG
    Curr Opin Psychiatry; 2009 Jan; 22(1):32-6. PubMed ID: 19122532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenines: from the perspective of major psychiatric disorders.
    Myint AM
    FEBS J; 2012 Apr; 279(8):1375-85. PubMed ID: 22404766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.